Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Kenneth Simonsen

Datos Biográficos

ID7656293
NOMBREKenneth Simonsen
NOMBRESKenneth
APELLIDOSimonsen
FIRMASIMONSEN K
AFILIACIONESLundbeck (Denmark)
VERIFICADONo
TOTAL DE OBRAS2
TOTAL DE CITAS0
TOTAL COMO AUTOR2
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2022
AÑO MÁS RECIENTE DE PUBLICACIÓN2023
ÍNDICE H0
  • Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice

    Open Access•Gregory W Mattingly, Gregory Mattingly et al.•ARTICLE•Frontiers in Psychiatry•2023

    This real-world study demonstrated improvements in functioning, depressive symptoms, and cognitive function in patients with MDD treated with vortioxetine in routine clinical practice in the cohort of patients enrolled in the United States. Outcomes were consistent with the efficacy and safety profile of vortioxetine in randomized controlled trials

  • Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice

    Open Access•Gregory W Mattingly, Hongye Ren et al.•ARTICLE•Frontiers in Psychiatry•2022

    These results demonstrate the effectiveness and tolerability of vortioxetine for the treatment of MDD in a large and heterogeneous patient population representative of that encountered in routine clinical practice

Sin obras prominentes en esta página.

  • Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice

    Open Access•Gregory W Mattingly, Hongye Ren et al.•ARTICLE•Frontiers in Psychiatry•2022

    These results demonstrate the effectiveness and tolerability of vortioxetine for the treatment of MDD in a large and heterogeneous patient population representative of that encountered in routine clinical practice

  • Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice

    Open Access•Gregory W Mattingly, Gregory Mattingly et al.•ARTICLE•Frontiers in Psychiatry•2023

    This real-world study demonstrated improvements in functioning, depressive symptoms, and cognitive function in patients with MDD treated with vortioxetine in routine clinical practice in the cohort of patients enrolled in the United States. Outcomes were consistent with the efficacy and safety profile of vortioxetine in randomized controlled trials

Adverse effect (2 obras) · Depression (economics (2 obras) · Internal Medicine (2 obras) · Major depressive disorder (2 obras) · Medicine (2 obras) · Psychiatry (2 obras) · Treatment of Major Depression (2 obras) · Vortioxetine (2 obras) · Anxiety (1 obras) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae